THE PHARMACEUTICAL BACKSTORY

We live in an era where bacterial infections are on the rise. The need of the hour is an extensive range of antibiotic and anti-infection injectables that are also highly efficient. Considering the fact that a vast number of Indians fall in the middle income group, these medications need to sold at reasonable prices, yet at the same time, they need to be designed to conform to all international standards of quality and safety.

If you’re an Injectables Manufacturer in India, you’re well aware of these facts. While bacterial infections are at one end of the spectrum of Injectables Manufacturing in India there are many conditions where injectables come into use. There are injectables for the treatment of cancer (also known as oncology), cardiovascular diseases, neurological disorders, and hormone therapies, to name a few.

It’s said that expansion of the generic pharmaceutical industry in the country has resulted in the advancement of synthetic process and formulation development skills inside the industry itself. Now when we delve into the arena of Pharma Research and Development in India, until around the year 1995, a large part of the research that was carried out by the Indian pharmaceutical institutions was associated with the development of procedure, formulation and bio-availability studies. Even though, a small number of multinational corporations had their own research facilities in the country, which had a wider capacity for innovation.

India’s direct involvement in recent years in the international drug development process for world’s largest pharmaceutical corporations has been a fascinating turn of events. The development is playing a tremendous role in India’s growth story; it is also bringing India’s innovative capabilities to the fore, while showcasing the country's core pharmaceutical competency and its highly skilled and qualified workforce at the global stage.

Additionally, the Pharma Research and Development backdrop in the country is going through a dramatic shift with the advent of Contract Research Organisations (CROs). Today, the core competencies of Indian CROs range from CRMs (Clinical Research Management), Site Management and Data Operations, to Drug Discovery, Toxicology, Genetic Science, and Bioinformatics and much more. Many of these CROs are operating as subsidiaries for large multinational Pharma companies.  

To know more,visit: www.cironpharma.in

From Drug Discovery to Development & Delivery

Today, almost all Indian pharmaceutical establishments are seeing great worth in committing their time and resources in research and development (R&D) of therapeutic drug and in their discovery. However, major pharmaceutical companies began to invest in Research and Development in India and new Pharmaceutical Formulations in India as early as three decades ago, in other words, in the '80s.

What sets a big, pioneering pharmaceutical company apart from the rest of the lot is its capacity to develop generic medicines as well as scientifically intricate remedies, with the help of their highly skilled teams working together in formulations, processes and analytics. Finally, it all comes down to the ability of the Pharma company to deliver the drug within set time limits, at competitive prices and, of course, without compromising on the standard quality of the final products.

Among the major pharmaceutical establishments in India, some of them have more than fifteen hundred scientific research professionals operating in numerous research & development hubs. These research scientists are known to work with the latest and the most advanced technological equipment for their research. The scientists possess all the expertise to develop the latest in generic drug, complex tech intensive offerings, Active Pharmaceutical Ingredients (known around the world as APIs), newer chemical entities and novel drug-delivery systems.

A very important aspect that major pharmaceutical companies have mastered is developing and nurturing a work ecosphere where their scientists can work side by side with their business development professionals. This symbiosis enables the scientists to generate innovative conceptions that cater to the market needs as well as for activities across various other therapeutic domains.

With Contract Research in India, Pharma companies across the country get a tremendous opportunity to give contracts to independent researching organisations which assist them in drug discovery and development. These unique, innovative and mutual relationships have earned pharmaceutical establishments rich dividends in terms of business, as well as helping them attain enviable reputation for their deliverance of high standards of quality, original solutions and competence.

To know more,visit:www.cironpharma.in

In Search of New Injectables

PharmaceuticalsResearch in India has grabbed attention from overseas market owing to qualified research scientists who have been incessantly searching new possibilities. Their inventions and discoveries have made countries feel proud and to flaunt their successful ingressions to the worldwide market. Ciron Pharmaceuticals has reached far ahead in the field of research and development and due to their extensive research practice from development of new applications for existing products to upgrading formulation efficiency and improving drug delivery systems Independent research and development department boast of well qualified chemists who take them on a new level in the domain of Pharma Research India. Their microbiological laboratory outfitted and well equipped with ultramodern high tech facilities to conduct various tests. Injectables Manufacturing India has reached way ahead and encompassed the major arena of global market, as it is injectables medicines features as the second most used class of drugs following oral medicines on the global market. Their usability is on higher side  for their reliability and   predictability. Ciron Pharmaceuticals has injectables in both liquid and powder form as antibiotics like Ampicillin, penicillin, Cephalosporin, and chlorampenicol, as well as anti malerial, antiulcers, anesthetics, painkillers, multivitamins and many more to know log on to www.cironpharma.in

Pharmaceutical – The World of Invention

What’s the value of bringing a drug to market first? In some cases, it may be less than you think.

There has been a long-running debate in the pharmaceutical industry about the value of being first to market. Companies spend considerable resources seeking to increase the odds of beating their competitors to market and often hassle about the commercial disadvantage of being late. In the high-stakes race to market for a novel drug class, companies firmly believe that every month of lead time ahead of a competitor is significant. . The industrial R&D in the country should actually be focused on this phase of technology development where laboratory models are scaled up and converted into commercially viable products/processes. Evolving a laboratory-proven idea into an implementable technology is a kind of effort, which the academic community does not appear to be fully geared towards, at least at present.

It’s not quite that simple. Analysis of Pharmaceutical Research in India confirms a weak first-to-market advantage on average, but with significant nuances dependent on market context. In many instances, the first-mover advantage actually vanishes, particularly when the lead time is short or when the first mover is a small company. At Ciron the team of talented scientist keeps their core focus on the upcoming problems & solutions, the revolutions invention in pharmaceutical world is always the prime target for Ciron. To know more about the Ciron world visit http://www.cironpharma.in/